Monitored Anesthesia Care Sedation Therapeutics
1. Lusedra patent expiration
Treatment: Sedative-hypnotic agent indicated for monitored anesthesia care (mac) sedation
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6204257 | EISAI INC | Water soluble prodrugs of hindered alcohols |
Jul, 2022
(3 years ago) | |
| US6872838 | EISAI INC | Water soluble prodrugs of hindered alcohols |
Aug, 2018
(7 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Chemical Entity Exclusivity(NCE) | Dec 12, 2013 |
Drugs and Companies using FOSPROPOFOL DISODIUM ingredient
NCE-1 date: 12 December, 2012
Market Authorisation Date: 12 December, 2008
Dosage: SOLUTION
More Information on Dosage
LUSEDRA family patents
